Status:

COMPLETED

Evaluation of the Chemo-mechanical Caries Removal Agent (BRIX3000®) in Primary Molars

Lead Sponsor:

King Abdulaziz University

Conditions:

Dental Caries

Eligibility:

All Genders

4-9 years

Phase:

NA

Brief Summary

Dental caries is one of the most prevalent chronic diseases in people worldwide. Traditional clinical treatment of dental decay has developed on the basis of the removal of carious tissues with high-s...

Detailed Description

Dental caries is one of the most prevalent chronic diseases in people worldwide. It results in localized dissolution and destruction of the calcified tooth tissues. The destruction of the dental struc...

Eligibility Criteria

Inclusion

  • Healthy and cooperative patients of age group 4-9 years.
  • Primary first/second molars with open occlusal carious lesion having moderated depth and clinically visible brownish color softened dentin.
  • No clinical signs or symptoms of pulp degeneration, such as tenderness to percussion and history of sinus tracts or swelling. Intraoral periapical radiographs with lesions having radiolucency extending into, but only confined to dentin.

Exclusion

  • Patients with any major and minor systemic illness.
  • Uncooperative patients that necessitate pharmacological dental treatment.
  • Primary molars with mobile teeth, arrested caries, restored teeth, non-vital teeth, no carious lesion, presence of developmental defects and non-restorable teeth.
  • Patients on any antibiotic regimen either on the day of treatment or for at least 2 weeks prior to the study.
  • Patients allergic to Latex.
  • Radiographic evidence of external or internal root resorption, furcal or periapical radiolucency.
  • Primary molars with more than half of the root length resorbed.
  • Children who did not attend and complete the second session of treatment.
  • Not approving to sign the consent.

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05427591

Start Date

October 1 2019

End Date

January 1 2021

Last Update

June 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

King Abdulaziz University, Dental University Hospital

Jeddah, Mecca Region, Saudi Arabia, 80209